FDA Warns of Higher Death Risk With Pepaxto in Multiple Myeloma

FDA Warns of Higher Death Risk With Pepaxto in Multiple Myeloma

The US Food and Drug Administration (FDA) has issued a safety alert regarding an increased risk of d...
read more
Paving the Way for Diversity in Clinical Trials

Paving the Way for Diversity in Clinical Trials

“I’m the first person in my circle of ...
read more